Keith stated that BIEL's Goal is no further diluti
Post# of 7805
(Total Views: 332)
Posted On: 08/25/2022 2:02:54 PM
Keith stated that BIEL's Goal is no further dilution
He feels they have a revenue stream set up to accomplish that Goal.
Stada & Adcock Ingram revenue have not yet hit the books. It takes time for a distributor to set everything up for a new product, it is coming.
The current Extra Strength RecoveryRx keeps the same electronics and battery as the original. It gains its increased power from a new antenna configuration. BIEL feels the FDA may not require a new 510k which means quick turnaround.
Synergy Corporation has signed an agreement with BIEL to market RecoveryRx in SAE, APAC, Africa, MENA. The agreement requires them to purchase 975,000 devices over the next 18 months.
Synergy Medical Device Division
Headquartered in Singapore, SYNERGY is the leading growth partner for medical device companies in Africa, PAN India & South East Asia. Our experts provide customized Market Expansion Services that include marketing and sales, distribution, regulatory consulting and specialized services like consignment inventory management.
With our expert therapeutic knowledge and long-standing relationships, we provide unrivaled reach into various hospital environments, including operating theaters, day surgery clinics, outpatient surgery units, dental clinics and diagnostic laboratories. Our fast and efficient distribution service includes medical consumables, round-the-clock delivery of life-saving products, as well as after-sales services for capital expenditure equipment.
A compliant approach with all legal requirements ensures that the quality of the product is guaranteed throughout the value chain. Our areas of interest currently include ICU Solutions, Radiography, Radiotherapy as well as cardiological stents, pacemakers, implants etc.
https://synergy-corporation.com/our-business/...al-devices
He feels they have a revenue stream set up to accomplish that Goal.
Stada & Adcock Ingram revenue have not yet hit the books. It takes time for a distributor to set everything up for a new product, it is coming.
The current Extra Strength RecoveryRx keeps the same electronics and battery as the original. It gains its increased power from a new antenna configuration. BIEL feels the FDA may not require a new 510k which means quick turnaround.
Synergy Corporation has signed an agreement with BIEL to market RecoveryRx in SAE, APAC, Africa, MENA. The agreement requires them to purchase 975,000 devices over the next 18 months.
Synergy Medical Device Division
Headquartered in Singapore, SYNERGY is the leading growth partner for medical device companies in Africa, PAN India & South East Asia. Our experts provide customized Market Expansion Services that include marketing and sales, distribution, regulatory consulting and specialized services like consignment inventory management.
With our expert therapeutic knowledge and long-standing relationships, we provide unrivaled reach into various hospital environments, including operating theaters, day surgery clinics, outpatient surgery units, dental clinics and diagnostic laboratories. Our fast and efficient distribution service includes medical consumables, round-the-clock delivery of life-saving products, as well as after-sales services for capital expenditure equipment.
A compliant approach with all legal requirements ensures that the quality of the product is guaranteed throughout the value chain. Our areas of interest currently include ICU Solutions, Radiography, Radiotherapy as well as cardiological stents, pacemakers, implants etc.
https://synergy-corporation.com/our-business/...al-devices
(3)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼